Prot# C1073-400: An Open Label Study of the Efficacy and Safety of CORLUX (mifepristone) in the Treatment of the Signs and Symptoms of Endogenous Cushing's Syndrome

Project: Research project

Project Details

StatusFinished
Effective start/end date8/7/08 → 8/7/11

Funding

  • Corcept Therapeutics Incorporated (C1073-400)